Dese de alta para crear alertas sobre sus instrumentos,
eventos económicos y autores favoritos
Registrarse gratis ¿Ya tiene una cuenta? Iniciar sesión
205,150
-3,040
-1,46%
Cotizaciones
Todos los instrumentos
- Todos los instrumentos
- Índices
- Acciones
- ETFs
- Fondos
- M. primas
- Divisas
- Cripto
- Bonos
- Certificados
Por favor, inténtelo con una nueva búsqueda
🚀 Valores elegidos por nuestra IA al alza en mayo. ¡PRFT+55% en sólo 16 días! No te pierdas las acciones de junio. Descarga la lista completa
Allianz Biotechnologie A Eur (0P00000CML)
Añadir/Eliminar de la cartera
Añadir a cartera
- Rating de Morningstar:
- Total activos: 305,82M
Tipo:
Fondo
Mercado:
Alemania
Emisor:
Allianz Global Investors GmbH
ISIN:
DE0008481862
Clase de activo:
Acción
Allianz Biotechnologie A EUR
205,150
-3,040
-1,46%
Resumen 0P00000CML
En esta página encontrará un perfil detallado de Allianz Biotechnologie A Eur. Conozca la gestión clave, los activos totales, la estrategia de inversión y la información de contacto de 0P00000CML, entre otros datos.
Información de contacto
Lugar
L-2633 Senningerberg
Frankfurt am Main, 60323
Germany
Frankfurt am Main, 60323
Germany
Teléfono fijo
+49 (0) 69 2443-1140
Fax
Frankfurt am Main
Ejecutivos destacados
| Nombre | Título | Desde | Hasta |
|---|---|---|---|
| Peter Pirsch | Senior Portfolio Manager | 2019 | Ahora |
| Biografía | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| Christopher Chin | - | 2019 | Ahora |
| Kimberlee W. Millar | Vice President | 2018 | 2021 |
| Biografía | Ms. Millar is a portfolio manager, analyst and director with Allianz Global Investors, which she joined in 2005. As a generalist for the Disciplined Equities group, her primary responsibility is conducting company research; she also helps improve the group’s overall investment processes and contributes toward its portfolio-management efforts. Ms. Millar has 23 years of investment industry experience. She previously worked as an assistant economist at the Investment Company Institute in Washington, D.C., producing mutual-fund-industry research for investment-management firms’ research and marketing departments. Before that, Ms. Millar worked at Heiden Associates Inc., an economic consulting firm in Washington, D.C. She has a B.A. in economics from the University of Calgary, Canada, and an M.A. in economics from Queen’s University, Canada. Ms. Millar is a CFA charterholder and a member of the CFA Institute. | ||
| Hugo Ong | - | 2018 | 2021 |
| Christopher Chin | - | 2018 | 2019 |
| Peter Pirsch | Senior Portfolio Manager | 2018 | 2019 |
| Biografía | Mr. Pirsch is a senior portfolio manager, a senior analyst and a director with Allianz Global Investors, which he joined in 2018. He has management and research responsibilities for the Health Care team. Mr. Pirsch has 20 years of investment-industry experience. He previously worked at Aptigon Capital, Visium Asset Management, Surveyor Capital, Fred Alger Management and C.R. Bard. Before that, Mr. Pirsch was an associate director at UBS Investment Bank and an analyst at Wells Fargo. He has a B.A. in economics and international relations from Bucknell University, and an M.B.A. with a certificate in health sector management from Duke University, Fuqua School of Business. Mr. Pirsch is a CFA charterholder. | ||
| John R. Schroer | Portfolio Manager | 2014 | 2018 |
| Biografía | Mr. Schroer, CFA, is a portfolio manager and a director with Allianz Global Investors, which he joined in 2014. He is the sector head of the Health Care team. He was previously the president of Schroer Capital, L.P.; an equity analyst with HealthCor Management, L.P.; a managing member and portfolio manager for ITROS Capital Management, LLC; a global partner, senior vice president, and portfolio manager for INVESCO; and an analyst for Trust Company of the West. Mr. Schroer has a B.S. in history and international relations and an M.B.A. in finance from the University of Wisconsin. | ||
| Paul A. Wagner | Senior Research Analyst | 2012 | 2014 |
| Biografía | Mr. Wagner, CFA, is a portfolio manager, a senior research analyst and a director with Allianz Global Investors, which he joined in 2006. He has biotechnology responsibilities for the US Health Care team and has 14 years of investment-industry experience. Mr. Wagner previously worked at PDL BioPharma in corporate and business development, and was a vice president and senior equity-research analyst in the biotechnology sector at Lehman Brothers. He has a B.S. in chemistry from the University of Wisconsin and a Ph.D. in chemistry from the California Institute of Technology. | ||
| Nicole Papassavvas | - | 2008 | 2012 |
| Javier Latorre | - | 2007 | 2012 |
Escribe tu comentario sobre Allianz Biotechnologie A Eur
¿Estás seguro que quieres borrar este gráfico?
Eliminar Cancelar
¿Sustituir el gráfico adjunto por un nuevo gráfico?
Sustituir Cancelar
Guía para comentarios
Adjuntar un gráfico al comentario
Confirmar bloqueo
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Denunciar este comentario
Díganos qué piensa de este comentario
Comentario denunciado
Gracias
Su denuncia será examinada por nuestros moderadores